EV/EBITDA
-0.88
+0.02+2.22%
73 min ago
Summary
- As of March 10, 2025, ABOS EV/EBITDA is -0.88, with a rise of +0.02 (+2.22%) during the most recent trading day.
- Over the past year, ABOS EV/EBITDA has increased by +3.36 (+79.25%).
- ABOS EV/EBITDA is now -282.61% below its all-time high of -0.23.
Performance
ABOS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ABOS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.2% | -2.6% | -2.4% |
| 1 m1 month | +16.2% | -16.2% | -15.3% |
| 3 m3 months | +47.6% | -47.4% | -45.8% |
| 6 m6 months | +53.7% | -38.3% | -51.4% |
| ytdytd | +29.6% | -29.6% | -28.2% |
| 1 y1 year | +79.3% | -68.6% | -72.5% |
| 5 y5 years | - | - | - |
ABOS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.1% | -1.06 | +17.0% | |
| 3 m | 3-month | -0.87 | -1.1% | -1.68 | +47.6% |
| 6 m | 6-month | -0.87 | -1.1% | -2.45 | +64.1% |
| 1 y | 1-year | -0.87 | -1.1% | -4.39 | +80.0% |
| 3 y | 3-year | -0.23 | -282.6% | -10.14 | +91.3% |
| 5 y | 5-year | -0.23 | -282.6% | -67.08 | +98.7% |
| alltime | all time | -0.23 | -282.6% | -67.08 | +98.7% |
Acumen Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.88(-29.6%) |
| 2024 | -1.25(-64.2%) |
| Date | Value |
|---|---|
| 2023 | -3.49(+71.9%) |
| 2022 | -2.03(-73.7%) |
| 2021 | -7.73 |
FAQ
- What is Acumen Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Acumen Pharmaceuticals?
- What is ABOS EV/EBITDA year-to-date change?
- What is Acumen Pharmaceuticals EV/EBITDA year-on-year change?
What is Acumen Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of ABOS is -0.88
What is the all time high EV/EBITDA for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high EV/EBITDA is -0.23
What is ABOS EV/EBITDA year-to-date change?
Acumen Pharmaceuticals EV/EBITDA has changed by +0.37 (+29.60%) since the beginning of the year
What is Acumen Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, ABOS EV/EBITDA has changed by +3.36 (+79.25%)